1. Home
  2. NSPR vs BGSF Comparison

NSPR vs BGSF Comparison

Compare NSPR & BGSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • BGSF
  • Stock Information
  • Founded
  • NSPR 2005
  • BGSF 2007
  • Country
  • NSPR Israel
  • BGSF United States
  • Employees
  • NSPR N/A
  • BGSF N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • BGSF Professional Services
  • Sector
  • NSPR Health Care
  • BGSF Consumer Discretionary
  • Exchange
  • NSPR Nasdaq
  • BGSF Nasdaq
  • Market Cap
  • NSPR 63.0M
  • BGSF 66.0M
  • IPO Year
  • NSPR N/A
  • BGSF N/A
  • Fundamental
  • Price
  • NSPR $3.19
  • BGSF $4.97
  • Analyst Decision
  • NSPR Strong Buy
  • BGSF
  • Analyst Count
  • NSPR 2
  • BGSF 0
  • Target Price
  • NSPR $4.75
  • BGSF N/A
  • AVG Volume (30 Days)
  • NSPR 50.3K
  • BGSF 11.3K
  • Earning Date
  • NSPR 03-05-2025
  • BGSF 03-12-2025
  • Dividend Yield
  • NSPR N/A
  • BGSF N/A
  • EPS Growth
  • NSPR N/A
  • BGSF N/A
  • EPS
  • NSPR N/A
  • BGSF N/A
  • Revenue
  • NSPR $6,821,000.00
  • BGSF $281,656,000.00
  • Revenue This Year
  • NSPR $13.36
  • BGSF N/A
  • Revenue Next Year
  • NSPR $49.64
  • BGSF $5.63
  • P/E Ratio
  • NSPR N/A
  • BGSF N/A
  • Revenue Growth
  • NSPR 24.70
  • BGSF N/A
  • 52 Week Low
  • NSPR $1.81
  • BGSF $4.70
  • 52 Week High
  • NSPR $3.42
  • BGSF $10.50
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 63.51
  • BGSF 39.14
  • Support Level
  • NSPR $2.60
  • BGSF $4.90
  • Resistance Level
  • NSPR $3.11
  • BGSF $5.19
  • Average True Range (ATR)
  • NSPR 0.28
  • BGSF 0.19
  • MACD
  • NSPR 0.05
  • BGSF 0.01
  • Stochastic Oscillator
  • NSPR 87.15
  • BGSF 40.30

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About BGSF BGSF Inc.

BGSF Inc is a provider of workforce solutions operating primarily in the U.S. across two segments: Property Management and Professional. In the Property Management segment, BGSF offers office and maintenance talent to clients, facilitating their staffing needs with short-term and consulting solutions. The Professional segment specializes in IT, offering skilled professionals in SAP, Workday, and other areas to Fortune 500 companies and consulting firms nationwide. BGSF's workforce services include on-demand assignments, consulting, and managed solutions, allowing clients to flexibly manage their workforce needs. With a focus on converting fixed personnel costs to variable expenses, BGSF enables companies to effectively address fluctuations in demand while optimizing costs.

Share on Social Networks: